(PBE) Invesco Dynamic - Ratings and Ratios

The Invesco Dynamic Biotechnology & Genome ETF (NYSE ARCA:PBE) is designed to provide exposure to the U.S. biotechnology and genome sectors by investing at least 90% of its total assets in securities that make up its underlying index. The fund focuses on companies primarily engaged in the research, development, manufacturing, and distribution of biotechnological products, services, and processes, including genetic engineering, gene editing, and genomics. It is classified as a non-diversified fund, meaning it can invest a significant portion of its assets in a limited number of securities, which may increase volatility. The fund is part of the Health sector and is listed on the NYSE ARCA under the ticker symbol PBE. For more information, visit http://www.invesco.com/us.

As of the latest data, the fund has an average 20-day volume of 6,467 shares, with a last price of $66.71. Its short-term and long-term moving averages (SMA 20: $68.00, SMA 50: $68.03, SMA 200: $68.14) indicate a stable price trend, with the 20-day average slightly below the longer-term averages. The Average True Range (ATR) of 0.99 suggests relatively low volatility. With assets under management (AUM) of $249.57M, the fund is moderately sized within its category. Over the next three months, based on and , the fund is expected to maintain a sideways trading range with minor fluctuations, supported by its current moving average structure and moderate AUM, which aligns with its historical price behavior.